维普中文期刊产品整合服务
17篇 您的检索式:作者名="Bassem S"
    题名 作者 年代 出处 被引量
1Efficiency of Microfinance Institutions in the Mediterranean: an Application of DEA显示文摘BASSEM B S 2008Transition Studies Review2008,15,2:1
2Efficiency of Microfinance Institutions in the Medite- rranean:An Application of DEA显示文摘Bassem B S 2008Transition Studies Review2008,,15:1
3An Estimation of Distribution Algorithm Forminimizing the Total Flowtime in Permutation Flowshop Scheduling Problems显示文摘Bassem J Mansour E Patrick S 2009Computers & Operations Research2009,36,:1
4Probabilistic modeling of chloride-induced corrosion in concrete structures using first-and second-order reliability methods显示文摘Bassem S Lounis Z 2012Cement and Concrete Composites2012,34,9:1
5Nozzle deposits in titanium treated stainless steels显示文摘Maddalena R Rastogi R Bassem S 2000Iron & Steel Maker2000,27,12:1
6Adsorption of hydrogen in covalent organic frameworks:Comparison of simulations and experiments 显示文摘Bassem A Gotthard S 2010Microporous andMesoporous Materials2010,133,:1
7Pore-throat characterization in highly porous and permeable sandstones显示文摘Bassem N S Géraud Y Rochette P 2009AAPG Bulletin2009,93,6:1
8显示文摘FIRASAT HUSSAIN BASSEM S B KORTZ U 2005Angew Chem Int Ed2005,43,:1
9Assessment of antimycotoxigenic and antioxidant activity of star anise (Illicium verum) in vitro显示文摘Soher E Aly Bassem A Sabry Mohamed S Shaheen 2014Journal of the Saudi Society of Agricultural Sciences2014,9,1:1
10Response surface optimi- zation for determination of volatile organic compounds in water samples by headspace-Gas Chromatography-Mass spectrometry method 显示文摘Ines M Lotfi S Bassem J 2009J Chromatogr Sci2009,47,4:1
11Urinary tract infection and indirect hyperbilirubinemia in newborns 显示文摘Omar C Hamza S Bassem AM 2011N Am J Med Sci2011,3,12:1
12Nozzle Deposits in Titanium Treated Stainless Steels 显示文摘Maddalena R Rastogi R Bassem S 2000Iron & Steelmaker2000,27,12:1
13Rotoresection versus transurethral resection of the prostate: short-term evaluation of a prospective randomized study显示文摘Shady A Soliman Bassem S Wadie El-Husseiny E Ibrahim 2007J Urol2007,177,:1
14Hepatic and gastrointestinal disturbances in Egyptian patients infected with coronavirus disease 2019: A multicentre cohort study显示文摘BACKGROUND Various liver and gastrointestinal involvements occur in patients with coronavirus disease 2019(COVID-19)at variable prevalence.Most studies report mild liver function disturbances correlated with COVID-19 severity,though liver failure is unusual.AIM To study liver and gastrointestinal dysfunctions in Egyptian patients with COVID-19 and their relation to disease outcomes METHODS This multicentre cohort study was conducted on 547 Egyptian patients from April 15,2020 to July 29,2020.Consecutive polymerase chain reaction-confirmed COVID-19 cases were included from four quarantine hospitals affiliated to the Egyptian ministry of health.Demographic information,laboratory characteristics,treatments,fibrosis-4(FIB-4)index,COVID-19 severity,and outcomes were recorded and compared according to the degree of liver enzyme elevation and the presence of gastrointestinal symptoms.Follow-ups were conducted until discharge or death.Regression analyses were performed to determine the independent factors affecting mortality.RESULTS This study included 547 patients,of whom 53(9.68%)died during hospitalization and 1 was discharged upon his request.Patients’mean age was 45.04±17.61 years,and 21.98%had severe or critical COVID-19.Alanine aminotransferase(ALT)and aspartate aminotransferase(AST)were available for 430 and 428 patients,respectively.In total,26%and 32%of patients had elevated ALT and AST,respectively.Significant liver injury with ALT or AST elevation exceeding 3-fold was recorded in 21(4.91%)and 16(3.73%)patients,respectively.Male gender,smoking,hypertension,chronic hepatitis C,and lung involvement were associated with elevated AST or ALT.AST was elevated in 50%of patients over 60-years-old.FIB-4 was significantly higher in patients admitted to the intensive care unit(ICU),those with more severe COVID-19,and non-survivors.The independent variables affecting outcome were supplementary vitamin C intake(1 g daily capsules)[odds ratio(OR):0.05,95%confidence interval(CI):0.008–0.337];lung consolidation(OR:4.540,95%CI:1.155–17.840);ICU admission(OR:25.032,95%CI:7.110–88.128);and FIB-4 score>3.25(OR:10.393,95%CI:2.459-43.925).Among 60(13.98%)patients with gastrointestinal symptoms,52(86.67%)had diarrhoea.Patients with gastrointestinal symptoms were predominantly females with higher body mass index,and 50(83.40%)patients had non-severe COVID-19.CONCLUSION Few Egyptian patients with COVID-19 developed a significant liver injury.The independent variables affecting mortality were supplementary vitamin C intake,lung consolidation,ICU admission,and FIB-4 score.Hend Ibrahim Shousha Shimaa Afify Rabab Maher Noha Asem Eman Fouad Ehab F Mostafa Mohammed A Medhat Amr Abdalazeem Hazem Elmorsy Miriam M Aziz Rateba S Mohammed Mohamed Ibrahem Hassan Elgarem Dalia Omran Mohamed Hassany Bassem Elsayed Ahmed Y Abdelaziz Mohamed El Kassas 2021World Journal of Gastroenterology2021,27,40:1
15Nozzle deposit s in tita- nium treated stainless steels 显示文摘Maddalena R Rastogi R Bassem S 2000Iron & Steelmaker2000,27,12:1
16Urinary tract infection and indirect hyperbilirubinemia in newborns显示文摘Omar C Hamza S Bassem AM 0,,12:1
17Impact of high dose vitamin C on platelet function显示文摘AIM To examine the effect of high doses of vitamin C(VitC) on ex vivo human platelets(PLTs).METHODS Platelet concentrates collected for therapeutic or prophylactic transfusions were exposed to:(1) normal saline(control);(2) 0.3 mmol/L VitC(Lo VitC); or(3) 3 mmol/L VitC(Hi VitC, final concentrations) and stored appropriately. The Vit C additive was preservative-free buffered ascorbic acid in water, pH 5.5 to 7.0, adjusted with sodium bicarbonate and sodium hydroxide. The doses of Vit C used here correspond to plasma Vit C levels reported in recently completed clinical trials. Prior to supplementation, a baseline sample was collected for analysis. PLTs were sampled again on days 2, 5 and 8 and assayed for changes in PLT function by: Thromboelastography(TEG), for changes in viscoelastic properties; aggregometry, for PLT aggregation and adenosine triphosphate(ATP) secretion in response to collagen or adenosine diphosphate(ADP); and flow cytometry, for changes in expression of CD-31, CD41 a, CD62 p and CD63. In addition, PLT intracellular Vit C content was measured using a fluorimetric assay for ascorbic acid and PLT poor plasma was used for plasma coagulation tests [prothrombin time(PT), partial thrombplastin time(PTT), functional fibrinogen] and Lipidomics analysis(UPLC ESI-MS/MS).RESULTS VitC supplementation significantly increased PLTs intracellular ascorbic acid levels from 1.2 mmol/L at baseline to 3.2 mmol/L(Lo VitC) and 15.7 mmol/L(Hi VitC, P < 0.05). VitC supplementation did not significantly change PT and PTT values, or functional fibrinogen levels over the 8 d exposure period(P > 0.05). PLT function assayed by TEG, aggregometry and flow cytometry was not significantly altered by Lo or Hi VitC for up to 5 d. However, PLTs exposed to 3 mmol/L VitC for 8 d demonstrated significantly increased R and K times by TEG and a decrease in the α-angle(P < 0.05). There was also a fall of 20 mm in maximum amplitude associated with the Hi VitC compared to both baseline and day 8 saline controls. Platelet aggregation studies, showed uniform declines in collagen and ADP-induced platelet aggregations over the 8-d study period in all three groups(P > 0.05). Collagen and ADP-induced ATP secretion was also not different between the three groups(P > 0.05). Finally, VitC at the higher dose(3 mmol/L) also induced the release of several eicosanoids including thromboxane B2 and prostaglandin E2, as well as products of arachidonic acid metabolism via the lipoxygenases pathway such as 11-/12-/15-hydroxyicosatetraenoic acid(P < 0.05).CONCLUSION Alterations in PLT function by exposure to 3 mmol/L VitC for 8 d suggest that caution should be exerted with prolonged use of intravenous high dose VitC.Bassem M Mohammed Kimberly W Sanford Bernard J Fisher Erika J Martin Daniel Contaifer Jr Urszula Osinska Warncke Dayanjan S Wijesinghe Charles E Chalfant Donald F Brophy Alpha A Fowler Ⅲ Ramesh Natarajan 2017World Journal of Critical Care Medicine2017,6,1:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费